StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)

Equities researchers at StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research report issued on Friday. The brokerage set a “hold” rating on the stock.

ObsEva Stock Down 100.0 %

ObsEva has a 52 week low of $0.08 and a 52 week high of $2.14. The stock has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.